The Mining Engineer will provide technical support to Mojave Quarry Operations and will lead the quarry operations in terms of safety, quality, and efficiency.
CalPortland is proud to offer a comprehensive, competitive benefits package that provides health and financial support to our most important resources: our employees. Your benefits are an important part of your overall compensation at CalPortland. That’s why we give you a wide range of benefits to choose from.
Salary $80-110k Annually DOE
Bachelor’s degree in Mining Engineering or related field preferred; degrees such as a degree in Civil Engineering or Geosciences may be acceptable depending on work experience.
Preferred:
Successful candidate must submit to a post-offer pre-employment physical examination, drug/alcohol screen, and background check. Some positions require Federal Motor Carrier Safety Administration (FMCSA) registration/clearance as well as ongoing alcohol and drug testing.
...that would rather outsmart the competition than outspend them. More than 40 years later, and this mantra is unwavering. We are a creatively-led agency who pinned our public reputation on our commitment to smarts. Smart brands create something of value in the world:...
...Wage: $19.50 - $22.50 per hour SUMMARY OF RESPONSIBILITIES: The Manager will oversee the day to day operation of the residential program by supervising, instructing, modeling and assisting Residential Trainers in providing direct services to the people of Chrysalis...
...DRIVERS IMMEDIATELY TO RUN LOCAL, REGIONAL AND OVER THE ROAD. GOOD PAY !!! MUST HAVE YOUR OWNCargo Vans, Sprinter Vans, Box / Straight Trucks, and 53' Dry Vans. Expedited / Hot Shot / Line haul, Routed work. Your earning potential is limited only by the hours...
...The Benefits Analyst is responsible for the administration, analysis, and optimization of employee benefits programs, including health... ...proficient in Microsoft Office and knowledge of HRIS systems (e.g., Workday, ADP). Strong analytical, communication, and problem-...
...ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024...